Owkin
Antonia Trower is an accomplished marketing professional with extensive experience in the biotechnology and healthcare sectors. Currently serving as VP of Marketing, Business & R&D at Owkin since November 2019, Antonia's role involves leveraging AI to optimize treatment options for patients. Previously, Antonia held the position of Marketing Manager at TargEDys, focusing on metabolic disease solutions, and was a Product Manager at Origin Sciences, where innovative medical devices for gastrointestinal diseases were developed. Antonia's career also includes project management at Loxbridge Research LLP and a medical marketing internship at Breast Cancer Haven. Antonia holds a degree in Cancer Biology and Immunology from the University of Bristol.
This person is not in any teams
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.